The best deals are not always the quickest to close, as Teva Pharmaceuticals learned in 2016 after its much-lauded acquisition of Allergan’s generic business, Actavis Generics. In its acquisition of ...

Actavis has sold an interest in its subsidiary in China to Zhejiang Chiral Medicine Chemicals Company. The Foshan, Guangdong-based interest has been divested just ten days after Actavis CEO said ...

Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) has settled another lawsuit alleging price fixing in the US. Teva ...

A greater proportion of women in the intervention group reported tolerable pain during placement and expressed a willingness ...

A decision in the 2013 U.S. Supreme Court case FTC v. Actavis found that while brand companies can be sued for engaging in reverse-payment, the payments themselves are not presumptively illegal.

Other cases in the US include the FTC's pursuit of AbbVie subsidiary Solvay and Actavis unit Watson on testosterone replacement therapy product Androgel, while in the EU Servier, Johnson & Johnson ...

This was the agency’s approach in “pay-for-delay” cases (branded drugs compensating generics to delay entry) that resulted in ...

US law firm Morgan Lewis & Bockius has hired Tim Powell, the co-founder of boutique IP firm Powell Gilbert, as a partner in ...

Attorneys general from 46 states and the District of Columbia expanded their antitrust case against the $75 billion generic drug industry to include 18 companies and at least 15 drugs. HARTFORD, Conn.

Global Adrenogenital Syndrome Treatment MarketThe global Adrenogenital Syndrome Treatment Market is expected to achieve significant growth, reaching a market value of USD 12.81 billion in 2023. With a ...

Michael L. Krychman, MD; Jan L. Shifren, MD, NCMP; James H. Liu, MD; Sheryl L. Kingsberg, PhD; Wulf H. Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS ...

The luxury gin brand has teamed up with the Italian shoe company on its first apparel collection, inspired by the brands' ...